Evotec

[search1]

[search1]

We strive to be the premier drug discovery and development partner for pharmaceutical and biotechnology companies. The Website is currently in the process of being updated. The new Website will be launched latest September 2009.

Recent News

Evotec Announces the Successful Completion of the First Phase I Study with EVT 401, an Oral P2X7 Receptor Antagonist - Very Good Safety Profile and Confirmed "On Target Activity"

Evotec Strengthens its Ion Channel Capabilities To Support New Alliances

Next Event

Optimised Lead Discovery

Berlin, Germany

Webcast

Piper Jaffray Europe Conference
June 24, 2009, 03.00 pm BST
(04.00 pm CEST, 10.00 am EDT)